Profil
Sheng Fu Liao is currently a Director-Supervisory Board at Yue Chang Investment Co. Ltd., Innova Health Care, Inc., and Innova Vision KK.
Previously, he served as a Director-Supervisory Board at Innova Vision Inc. He also worked as a Manager-Finance at Taiwan Mask Corp.
from 1999 to 2018.
Additionally, he was a Member-Supervisory Board at Advagene Biopharma Co., Ltd. from 2016 to 2019.
Mr. Liao is a graduate of National Cheng Kung University.
Aktiva positioner av Sheng Fu Liao
| Företag | Position | Start |
|---|---|---|
Innova Vision KK | Direktör/Styrelseledamot | 2011-02-17 |
Innova Health Care, Inc. | Direktör/Styrelseledamot | 2011-02-17 |
Yue Chang Investment Co. Ltd. /Taiwanmask/ | Direktör/Styrelseledamot | - |
Tidigare kända positioner av Sheng Fu Liao
| Företag | Position | Slut |
|---|---|---|
| ADVAGENE BIOPHARMA CO., LTD. | Direktör/Styrelseledamot | 2019-05-23 |
| TAIWAN MASK CORPORATION | Finansdirektör/CFO | 2018-01-15 |
Innova Vision Inc.
Innova Vision Inc. Medical SpecialtiesHealth Technology Manufactures medical equipment | Direktör/Styrelseledamot | - |
Sheng Fu Liaos utbildningar
Erfarenheter
Innehade positioner
Aktiva
Inaktiva
Börsnoterade företag
Privata företag
Relationer
Första gradens relationer
Företag kopplade till första graden
Man
Kvinna
Styrelseledamöter
Chefer
Kopplade företag
| Privata företag | 7 |
|---|---|
Taiwan Mask Corp.
Taiwan Mask Corp. SemiconductorsElectronic Technology Designs, manufactures and distributes reticles & photomasks | Electronic Technology |
Yue Chang Investment Co. Ltd. /Taiwanmask/ | |
National Cheng Kung University
National Cheng Kung University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Innova Vision Inc.
Innova Vision Inc. Medical SpecialtiesHealth Technology Manufactures medical equipment | Health Technology |
Innova Health Care, Inc. | |
Innova Vision KK | |
Advagene Biopharma Co., Ltd.
Advagene Biopharma Co., Ltd. BiotechnologyHealth Technology Engages in the development of products such as nasal influenza vaccine, airway allergy immunotherapy and COVID-19 immunotherapy | Health Technology |
















